Previous close | 0.7700 |
Open | 0.8085 |
Bid | 0.8075 x 0 |
Ask | 0.8080 x 0 |
Day's range | 0.7725 - 0.8090 |
52-week range | 0.7035 - 5.4500 |
Volume | |
Avg. volume | 43,798 |
Market cap | 28.515M |
Beta (5Y monthly) | 0.83 |
PE ratio (TTM) | N/A |
EPS (TTM) | -17.0100 |
Earnings date | 28 Mar 2023 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
KemPharm (KMPH) inks deal to acquire Orphazyme A/S, which will add to its portfolio the latter's pipeline candidate, arimoclomol, being developed for treating Niemann-Pick disease type C. Shares rise.